SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Half Yearly Report

26 Aug 2015 07:00

RNS Number : 0809X
Carillion PLC
26 August 2015
 



 

 

26 August 2015

 

Half-yearly financial report for the six months ended 30 June 2015

Performance in line with expectations

 

Six months ended

30 June 2015

Six months ended

30 June 2014

 

Change

Revenue

£2,258.6m

£1,871.0m

+21%

Underlying profit from operations(1)

£112.5m

£97.4m

+16%

Underlying operating margin(1)

5.1%

5.5%

n/a

Underlying profit before taxation(1)

£84.5m

£75.9m

+11%

Underlying earnings per share(1)

15.9p

14.7p

+8%

Profit before taxation

£67.5m

£67.5m

-

Basic earnings per share

12.7p

13.2p

-4%

Interim dividend per share

5.7p

5.6p

+2%

Underlying profit from operations cash conversion(1)

101%

127%

n/a

 

 

· First-half financial performance in line with expectations

- Strong first-half revenue growth reflected the exceptional volume of new contracts won in 2014

- Underlying profit and earnings grew strongly, despite substantial costs of mobilising new contracts and the expected effect of the margin in Construction services (excluding the Middle East) trending down towards a more normal level

- Strong cash flow from operations with underlying operating cash conversion(1) of 101% (2014: 127%)

- Net borrowing at 30 June 2015 of £199.6 million (31 December 2014: £177.3 million) reflected increases in non-operating cash flow items, including business acquisition costs and other investments

- Balance sheet remains strong with over £1.3 billion of committed funding available to the Group

 

· Strong, high-quality order book and growing pipeline of contract opportunities

- New first-half orders plus probable orders of £1.0 billion (2014: £3.2 billion) reflected the expected pause in public sector contract awards due to the UK General Election

- Total secure orders plus probable orders remained strong at £17.1 billion at 30 June 2015 (31 December 2014: £18.6 billion), after removing £0.2 billion from the order book due to PPP equity sales

- Revenue visibility(2) for 2015 of 96% at 30 June 2015 (2014: 93%)

- Framework contracts worth up to £2.5 billion, which are not included in orders or probable orders

- Pipeline of contract opportunities increased to £40.5 billion (31 December 2014: £39.2 billion)

 

· Interim dividend increased by 2% to 5.7p (2014: 5.6p)

 

· On track to deliver full-year revenue growth with profit and earnings in line with expectations

 

1. The underlying results stated above are based on the definitions included in the key financial figures.

2. Based on expected revenue and secure and probable orders, which exclude variable work,

frameworks and re-bids.

 

 

Carillion Chairman, Philip Green, commented:

 

"I am pleased to report that Carillion has continued to perform in line with expectations, which reflects the actions we took during the economic downturn to position our businesses in markets where we can now achieve revenue growth, consistent with our targets for margins and cash flow. We have also made good progress with mobilising a number of major new contracts won in 2014. Therefore, with a strong order book, a growing pipeline of contract opportunities and the prospect of market conditions continuing to improve, our expectations for 2015 and the medium term remain unchanged."

 

There will be a presentation for analysts and investors today at 09.00am. A telephone dial in facility tel: +44 1296 311600 - Access Code: 318 357.  A replay facility is also available for 30 days, the telephone number is +44 207 136 9233 - Access Code: 34863982 - if dialling in from overseas, please review the link attached for your dial in telephone number http://www.conferencingsupport.com/globalaccess/?bid=00&itfn=1&ddi=1&ref. Carillion Analyst Presentation will be available for analysts and investors who are unable to attend the presentation. The presentation can be viewed on Carillion's website at http://www.carillionplc.com/investors/reports-presentations.aspx

 

For further information contact:

Richard Adam, Group Finance Director

John Denning, Group Corporate Affairs Director

Finsbury - James Murgatroyd and Gordon Simpson

tel: +44 (0) 1902 422431

tel: +44 (0) 1902 422431

tel: +44 (0) 20 7251 3801

 

26 August 2015

 

Notes to Editors:

Carillion is a leading integrated support services company with a substantial portfolio of Public Private Partnership projects, extensive construction capabilities and a sector leading ability to deliver sustainable solutions. The Group had annual revenue in 2014 of some £4.1 billion, employs around 46,000 people and operates across the UK, in the Middle East and Canada.

 

The Group has four business segments:

 

Support services - this includes facilities management, facilities services, energy services, utilities services, road maintenance, rail services and consultancy businesses in the UK, Canada and the Middle East.

 

Public Private Partnership (PPP) projects - this includes investing activities in PPP projects for Government buildings and infrastructure mainly in the Defence, Health, Education, Transport and Secure accommodation sectors in the UK and Canada.

 

Middle East construction services - this includes building and civil engineering activities in the Middle East.

 

Construction services (excluding the Middle East) - this includes building, civil engineering and developments activities in the UK and construction activities in Canada.

 

This and other Carillion news releases can be found at www.carillionplc.com.

 

Photographs:

High resolution photographs are available free of charge to the media at www.newscast.co.uk telephone + 44 (0) 208 886 5895.

 

Cautionary statement

This announcement may contain indications of likely future developments and other forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. These and other factors could adversely affect the Group's results, strategy and prospects. Forward-looking statements involve risks, uncertainties and assumptions. They relate to events and/or depend on circumstances in the future which could cause actual results and outcomes to differ materially from those currently anticipated. No obligation is assumed to update any forward-looking statements, whether as a result of new information, future events or otherwise. 

For the full announcement please click on this link http://www.rns-pdf.londonstockexchange.com/rns/0809X_1-2015-8-25.pdf

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UVUWRVUAWUAR
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.